Seeking Alpha

BCRX
BioCryst Pharmaceuticals, Inc. - NASDAQ

4/17/2014, 5:39 AM ET
Quote & Analysis Breaking News StockTalk
bcrx chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There are 2 articles on this stock available only to PRO subscribers.
Other Articles
BCRX vs. ETF Alternatives
Company Description

Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.

Sector: Healthcare
Industry: Biotechnology
Country: United States